Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sun Biopharma Inc (SNBP)

Sun Biopharma Inc (SNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,290
  • Shares Outstanding, K 9,649
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SNBP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.21
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.71 +27.31%
on 11/02/20
3.72 -7.27%
on 11/16/20
+0.54 (+18.56%)
since 10/30/20
3-Month
2.37 +45.56%
on 09/04/20
3.72 -7.27%
on 11/16/20
+0.69 (+25.00%)
since 09/01/20
52-Week
2.37 +45.56%
on 09/04/20
10.00 -65.50%
on 07/14/20
-0.84 (-19.58%)
since 11/25/19

Most Recent Stories

More News
Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Line Metastatic Pancreatic Cancer

· Phase 1b Data Expected 1H 2021

SNBP : 3.45 (+0.29%)
PBLA : 0.3302 (-4.29%)
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.

MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer,...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results

MINNEAPOLIS, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select Conference

MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Schedules Conference Call on November 12, 2020 to Report 2020 Third Quarter Financial Results

MINNEAPOLIS, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)

Business Summary

Sun BioPharma Inc. is a clinical-stage biopharmaceutical company. It engages in developing disruptive therapeutics for patients with urgent unmet medical needs. The company's product pipeline consist SBP-101 for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Sun BioPharma...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 3.56
1st Resistance Point 3.51
Last Price 3.45
1st Support Level 3.38
2nd Support Level 3.30
3rd Support Level N/A

See More

52-Week High 10.00
Fibonacci 61.8% 7.09
Fibonacci 50% 6.19
Fibonacci 38.2% 5.28
Last Price 3.45
52-Week Low 2.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar